DRKS00000383已完成未知
Impact of milk-phospholipids compared to triacylglycerols on risk factors related to metabolic syndrome
Max Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebnsmittel0 个研究点目标入组 62 人开始时间: 2010年4月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 50 Years 至 75 Years(—)
- 性别
- Male
入选标准
- •Male gender, overweight
- •Between 50 and 75 years of age
- •Non-smoker
- •Subjects who gave written consent to participate in this study
排除标准
- •Subjects with fasting glucose above 120 mg/dl
- •Subjects suffering from a disease regarding the resorption of nutrients, digestive function, metabolism, or excretion
- •Subjects with a known milk protein allergy
- •Subjects taking nutritional supplements during the trial period which can influence study parameters
- •Subjects taking medications which can influence study parameters
- •Subjects that underwent surgery of the gastrointestinal tract or a corticoid treatment within the past three months
- •Subjects with an above average consumption of milk and milk products
- •Subjects experiencing unjustifiable adverse events
- •Subjects experiencing acute gastrointestinal disease during the trial period
- •Subjects who do not act compliantly
- •Subjects who withdraw their consent to participate in the study
研究者
相似试验
已完成
不适用
Influence of milk as compared to soy phospholipids on risk factors for cardiovascular diseaseE78.9Disorder of lipoprotein metabolism, unspecifiedDRKS00003125Max Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebensmittel58
已完成
不适用
Effect of Dietary Phospholipids on Atopic DermatitisDermatitis, AtopicNCT01326520University of Jena39
已完成
不适用
Phospholipid Absorption of a Milk PhospholipidHealthyNCT01327430University of Jena15
已完成
不适用
ipid emulsions and the control of body weight. Delivery Systems Study.Diet & NutritionDiet and Nutrition - ObesityACTRN12609000851268actopharma18
已完成
不适用
ipid emulsions and the control of body weight. Main Study.ACTRN12609000853246actopharma18
